Isomorphic Labs raises $5 billion Series C for AI-driven drug discovery
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Isomorphic Labs, the AI drug-discovery startup founded by former Google DeepMind chief Demis Hassabis, said on Tuesday it raised $5 billion in Series C funding, three and a half months after Hassabis stepped back as DeepMind CEO. Greenoaks and Sequoia co-led the round, with Andreessen Horowitz and Alphabet investing. Hassabis, CEO since the 2021 spinout from DeepMind, said the money will speed foundational biology models, disease understanding, and therapeutic programs toward clinical trials.
Continue in the app — vote & join in ➔Source: CNBC Top News · via ahirlevel.hu